Astrocyte characterization in the multiple sclerosis glial scar. - sprookjes - yvandenbroek - TriplyDB

Astrocyte characterization in the multiple sclerosis glial scar.

Astrocyte characterization in the multiple sclerosis glial scar.

http://www.wikidata.org/entity/Q48190222

about

The innate immune system in demyelinating disease Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair The Role of Astrocytes in Multiple Sclerosis Progression Function of microglia and macrophages in secondary damage after spinal cord injury New aspects of the pathogenesis of canine distemper leukoencephalitis Peroxiredoxin V in multiple sclerosis lesions: predominant expression by astrocytes Astrocytes in multiple sclerosis: a product of their environment Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination White matter astrocytes in health and disease.Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes.Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.Insulin-like growth factor-I gene delivery to astrocytes reduces their inflammatory response to lipopolysaccharide Treatment with Anti-EGF Ab Ameliorates Experimental Autoimmune Encephalomyelitis via Induction of Neurogenesis and Oligodendrogenesis The 14-3-3 protein epsilon isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes Endogenous cell repair of chronic demyelination.Retroviral lineage analysis of fibroblast growth factor receptor signaling in FGF2 inhibition of oligodendrocyte progenitor differentiation Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.Nigella sativa amliorates inflammation and demyelination in the experimental autoimmune encephalomyelitis-induced Wistar rats Extracellular environment contribution to astrogliosis-lessons learned from a tissue engineered 3D model of the glial scar Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes.Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis.Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord.Growth factor regulation of remyelination: behind the growing interest in endogenous cell repair of the CNS.Complement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis.Myelin repair strategies: a cellular view.Loss of Na+ channel beta2 subunits is neuroprotective in a mouse model of multiple sclerosis.Anorexia Reduces GFAP+ Cell Density in the Rat Hippocampus The crucial role of Erk2 in demyelinating inflammation in the central nervous system.Immunological demyelination triggers macrophage/microglial cells activation without inducing astrogliosis.Astrocyte-neuron interactions in neurological disorders.Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.Reactivated astrocytes as a possible source of oligodendrocyte precursors for remyelination in remitting phase of experimental autoimmune encephalomyelitis rats.The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment.Astrocyte-secreted matricellular proteins in CNS remodelling during development and disease Vitamin D therapy in experimental allergic encephalomyelitis could be limited by opposing effects of sphingosine 1-phosphate and gelsolin dysregulation.Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.

P2860

Q24597958-276974AD-3BE8-44B6-B9A1-64C1C90D276C Q26739719-86F1E233-19CF-424E-8084-321D6AD022B5 Q26782843-88216BA5-2F4E-4ED1-8ADE-EEA96B1AC7E6 Q27024453-0AC1DF1E-7336-464B-AB2E-C852C2D7BF86 Q27026660-BFC76512-FB48-461B-9B5D-57CCC9AB6AE3 Q28236048-8F70E020-9DFE-409C-8F77-69E46C1C0790 Q28282324-4D55DC47-0B4E-4DED-B978-43CBFB3F2837 Q29248440-B56AC8DE-96E6-4759-84ED-661C56B630A3 Q33594651-D9EC42D8-2959-4AE3-BDCF-6561DEDD0D82 Q33644063-266A3EE5-74E6-41DA-A25C-9159E09E6234 Q33674869-857A6109-4B88-410E-A398-871940147ED7 Q33841090-125030CD-54E9-411B-B391-14B607B64C79 Q34490581-C1D652EF-AA5B-4956-83A8-143931DA068C Q34668541-F28636DA-9F6B-4224-8468-C97B2B6A92E6 Q34970564-767054EF-636D-416A-AA6D-1278156BE0BF Q35103017-53C609A3-074A-4298-8BAB-A3E97FEE0821 Q35129300-09A6BB26-8324-42A7-B0DC-F38EAE6AD0CC Q35809314-46CE4530-80D0-483D-9C3D-36482BCF7ABB Q35825970-722E2645-EF46-4FC8-90E4-E177EDD0AD5E Q35910761-63DCFE56-E034-4542-9F61-0A9339E74C33 Q35918951-1A9670E8-434C-4718-94DE-6BCCA305AFE5 Q36103299-06B04357-3273-480A-9AF2-AA2CA2BD66AC Q36148455-A5ADF50F-5A4B-4E8F-81A6-4F2C23AFBFEC Q36286370-4A1FDD9E-CE59-4544-A8B2-3355206E4C68 Q36355088-66590AC2-59A2-40D3-B7DC-A387DEC4CC72 Q36727013-DF0732B0-E38E-496F-9EFF-5AEA31D907F0 Q37012791-8353CF2D-23EC-4791-B6D8-349ED6B46E08 Q37034172-D8B09717-8CA0-4140-97B6-C05E4D566F06 Q37152685-9CB8450A-A6D4-411D-BF9B-0A7592DEEBFF Q37161778-252C68A9-EBAE-4226-96B7-81654518C2D8 Q37192505-E34A8529-85BA-4806-BA26-D236A8FD1023 Q37233328-E611DD5F-97F0-4881-BF9C-6F06334A6707 Q37351589-A5AFCBF2-E276-4D4C-A26C-96678159732B Q37361072-78BBF2C5-10D9-424F-BCE7-4C936124B6EE Q37372509-93A16CF0-B205-4575-9F77-F8CAEFAAE49E Q37553848-56A6C871-D9F5-44E1-AD5B-1632D0FF31B4 Q38111421-710275D2-1F8A-4629-98FF-1B439AD62F95 Q38189382-C328B453-773B-49DB-824D-79E6C220FA1B Q39005334-3CDD33CA-8AFF-445A-92A2-53531AF28AE4 Q39279957-E18F54E5-64E0-43C9-B136-E347C29AE3C6

P2860

Astrocyte characterization in the multiple sclerosis glial scar.

http://www.wikidata.org/entity/Q48190222

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Astrocyte characterization in the multiple sclerosis glial scar.

@en

Astrocyte characterization in the multiple sclerosis glial scar.

@nl

type

label

Astrocyte characterization in the multiple sclerosis glial scar.

@en

Astrocyte characterization in the multiple sclerosis glial scar.

@nl

prefLabel

Astrocyte characterization in the multiple sclerosis glial scar.

@en

Astrocyte characterization in the multiple sclerosis glial scar.

@nl

P1433

Q48190222-811D2E6E-6464-4F48-BFC1-6F20EE3FA332

P1476

Q48190222-1BE8896D-E4F9-42F0-B71E-96FE6C7A0252

P2093

Q48190222-1B48DD24-0D2C-404D-B34E-2BDD66A989BE

Q48190222-1F8A7CB9-FE5C-44A3-AA60-014C15B5B824

Q48190222-3A152B1B-68C0-4C20-B4F1-3D76F1FC4D39

Q48190222-47A087EA-E2CD-4235-A179-137BF783D54C

Q48190222-FA04E3E8-9FF5-4E59-BA92-2D288BF8F292

P2860

Q48190222-370B2AC5-F13A-4BAF-AE43-947BB9EA1ACD

Q48190222-4AC9C76C-3F51-42A9-A18F-1624F0EE9F28

Q48190222-663FA18E-6D3C-4789-B8F2-163A8776A797

Q48190222-791523BF-5C02-4EB5-8AB2-68669E6A7225

Q48190222-7983CBD7-D731-40DC-A351-7B353352C544

Q48190222-7B0FB308-445E-4E5F-B39F-6899FDA1DFC4

Q48190222-7D7A57F7-8D87-4A15-B619-CCC52CCF095B

Q48190222-7D92CC0F-41A6-4D93-9B96-0BEE31F7AD8F

Q48190222-A46BECAC-DA90-46DD-877C-EE661A67F40A

Q48190222-A685045D-CF5D-4DCA-9265-84E798ADEEAA

P304

Q48190222-4EB1CC93-1C6C-43FE-A6C4-A4EFBFD6F532

P31

Q48190222-93B4689A-1876-4D53-AADE-539CC7F4D0C2

P356

Q48190222-BAEC07AE-0349-44A1-BF51-C59E7C1E4763

P433

Q48190222-3E9B9996-C093-4079-A61F-4A431DEB58B8

P478

Q48190222-F36F85EA-CDBC-4684-B1C8-9BCF0971E9F4

P577

Q48190222-87C00CEC-1D5D-4D9D-8A3A-8008A71DC4B1

P5875

Q48190222-51F1A00F-3835-4917-B157-85A1AC30D662

P698

Q48190222-A6569365-8547-4742-A203-5B85C1AE7E47

P921

Q48190222-C176E6BD-C107-444B-965C-381EDC3A4907

Q48190222-dc435022-d5d4-4370-b31f-f8d8ee17a9c5

P356

J.1365-2990.2003.00491.X

P1433

Neuropathology and Applied Neurobiology

P1476

Astrocyte characterization in the multiple sclerosis glial scar.

@en

P2093

D Gveric

http://www.w3.org/2001/XMLSchema#string

J E Holley

http://www.w3.org/2001/XMLSchema#string

J Newcombe

http://www.w3.org/2001/XMLSchema#string

M L Cuzner

http://www.w3.org/2001/XMLSchema#string

N J Gutowski

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Coexpression of nestin in neural and glial cells in the developing human CNS defined by a human-specific anti-nestin antibody

PSA-NCAM distinguishes reactive astrocytes in 6-OHDA-lesioned substantia nigra from those in the striatal terminal fields.

Transcriptional regulation of fibroblast growth factor-2 expression in human astrocytes: implications for cell plasticity.

Reactive astrocytes: cellular and molecular cues to biological function.

Differential cellular accumulation of connective tissue growth factor defines a subset of reactive astrocytes, invading fibroblasts, and endothelial cells following central nervous system injury in rats and humans.

The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease.

Regulation of cell adhesion by polysialic acid. Effects on cadherin, immunoglobulin cell adhesion molecule, and integrin function and independence from neural cell adhesion molecule binding or signaling activity.

Epidermal growth factor receptor immunoreactivity in rat brain astrocytes. Response to injury.

Localization of fibroblast growth factor 2 (FGF-2) protein and the receptors FGFR 1-4 in normal human seminiferous epithelium.

P304

434-444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2990.2003.00491.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9083044

http://www.w3.org/2001/XMLSchema#string

P698

14507335

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis